$1.370
-0.232 (-16.97%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SER por análisis de gráficos similares
Alphio's SER stock price prediction model matches the current Serina Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.38 (+0.91%). The 1-week path is $1.38 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Serina Therapeutics Inc?
Serina Therapeutics Inc is a good buy right now due to its recent positive developments and potential for growth. The stock is currently priced at $1.85, significantly below its 52-week high of $4.99, indicating a potential upside. Additionally, the RSI is at 56.234, suggesting that the stock is not overbought, which is favorable for entry. The recent partnership with Gannet BioChem and FDA approval for SER-252 could drive future growth, with analysts projecting a price target of $8, which represents a potential upside of over 300%. However, the main risk is the negative earnings trend, with a reported EPS of -0.58 in the last quarter, indicating ongoing financial challenges.
SER cerró en $1.37 el Friday, tras bajar -16.97%
Serina Therapeutics Inc (SER) last closed at $1.37, losing -16.97%. These facts feed the 1-day and 1-week SER price prediction above.
Factores de la previsión
Los factores de la previsión de Serina Therapeutics Inc (SER) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SER, ordenadas por similitud.
Análisis de estacionalidad de SER
Historically the probability of a positive November return for SER is 0.00%. August offers the highest probability of a positive month at 59.38%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SER
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $5.12 | $6.47 | $7.83 | +372.42% |
| Dec 2026 | $4.51 | $5.16 | $6.43 | +276.93% |
En 2026, se proyecta que Serina Therapeutics Inc (SER) oscile entre $4.51 y $7.83.
Previsión mensual de Serina Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Serina Therapeutics Inc promedie $6.47, con un mínimo de $5.12 y un máximo de $7.83.
En Dec de 2026, se proyecta que Serina Therapeutics Inc promedie $5.16, con un mínimo de $4.51 y un máximo de $6.43.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.